Dr. Malone has extensive research and development experience in the areas of clinical trials, vaccines, gene therapy, bio-defense, and immunology. He has over twenty years of management and leadership experience in the academia, pharmaceutical and biotech industries. His FDA, HHS, and DoD agency knowledge is extensive. Dr. Malone is an internationally recognized scientist and is known as one of the original inventors of “DNA Vaccination.”

Jeffrey has held numerous senior positions – including chief executive, chief financial, chief operating and chief strategic planning officer and member of the board of directors. He has planned and commercialized new businesses and product lines. Jeffrey has also orchestrated major transactions including $1.3 billion in public securities, $100 million in divestures, $1 billion in acquisitions, and $30 million in private securities.

Dr. Glasspool has experience in preclinical, regulatory, and clinical project management, with special expertise in public policy and Federal regulatory issues. Dr. Glasspool has held supervisory and management positions in the biotechnology industry and academia. She also was a co-founder of Inovio, USA, and Intradigm Corp. She has an extensive publication record.